| Paul C Keenan Jr, MD | |
|
216 Mill St, Bristol, PA 19007-4809 | |
| (215) 781-2020 | |
| (215) 788-3504 |
| Full Name | Paul C Keenan Jr |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 41 Years |
| Location | 216 Mill St, Bristol, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588671879 | NPI | - | NPPES |
| 101161546 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207WX0120X | Ophthalmology - Cornea And External Diseases Specialist | MD040571L (Pennsylvania) | Secondary |
| 207W00000X | Ophthalmology | MD040571L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sovah Health Danville | Danville, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| David M Harman Md Llc | 6305828062 | 45 |
News Archive
Wayne State researchers have for the first time observed the movement of a single molecule of DNA polymerase as it incorporates nucleotides one by one. More significantly, they have identified a previously unknown step that they speculate is part of the proofreading process known to prevent the polymerase from producing cancer-causing mutations.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, and Topotarget A/S announced today that the first patient has been dosed in an Investigator Initiated Trial of belinostat in combination with Tarceva® for patients with Non-Small Cell Lung Cancer (NSCLC).
Philadelphia Inquirer: Efforts by N.J. Senate Democrats to restore $7.5 million to state family planning health centers ended Monday without any Republican support. In a 23-17 party line vote the Senate failed veto the governor's veto of center funding. Gov. "Christie's budget eliminated state funding to 58 family-planning health centers across the state, which last year provided services to more than 130,000 men and women, most of whom were underinsured.
The United States Congressional Budget Office estimates that 5 percent of the country's gross domestic product is spent on medical tests and procedures that do not improve patient outcomes.
› Verified 6 days ago
| Entity Name | David M Harman Md Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306950431 PECOS PAC ID: 6305828062 Enrollment ID: O20040605000053 |
News Archive
Wayne State researchers have for the first time observed the movement of a single molecule of DNA polymerase as it incorporates nucleotides one by one. More significantly, they have identified a previously unknown step that they speculate is part of the proofreading process known to prevent the polymerase from producing cancer-causing mutations.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, and Topotarget A/S announced today that the first patient has been dosed in an Investigator Initiated Trial of belinostat in combination with Tarceva® for patients with Non-Small Cell Lung Cancer (NSCLC).
Philadelphia Inquirer: Efforts by N.J. Senate Democrats to restore $7.5 million to state family planning health centers ended Monday without any Republican support. In a 23-17 party line vote the Senate failed veto the governor's veto of center funding. Gov. "Christie's budget eliminated state funding to 58 family-planning health centers across the state, which last year provided services to more than 130,000 men and women, most of whom were underinsured.
The United States Congressional Budget Office estimates that 5 percent of the country's gross domestic product is spent on medical tests and procedures that do not improve patient outcomes.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paul C Keenan Jr, MD 216 Mill St, Bristol, PA 19007-4809 Ph: (215) 781-2020 | Paul C Keenan Jr, MD 216 Mill St, Bristol, PA 19007-4809 Ph: (215) 781-2020 |
News Archive
Wayne State researchers have for the first time observed the movement of a single molecule of DNA polymerase as it incorporates nucleotides one by one. More significantly, they have identified a previously unknown step that they speculate is part of the proofreading process known to prevent the polymerase from producing cancer-causing mutations.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, and Topotarget A/S announced today that the first patient has been dosed in an Investigator Initiated Trial of belinostat in combination with Tarceva® for patients with Non-Small Cell Lung Cancer (NSCLC).
Philadelphia Inquirer: Efforts by N.J. Senate Democrats to restore $7.5 million to state family planning health centers ended Monday without any Republican support. In a 23-17 party line vote the Senate failed veto the governor's veto of center funding. Gov. "Christie's budget eliminated state funding to 58 family-planning health centers across the state, which last year provided services to more than 130,000 men and women, most of whom were underinsured.
The United States Congressional Budget Office estimates that 5 percent of the country's gross domestic product is spent on medical tests and procedures that do not improve patient outcomes.
› Verified 6 days ago
Mark C Montag, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 216 Mill Street, Bristol, PA 19007 Phone: 215-781-2020 Fax: 215-781-6794 | |
Charles Edward Brodowski, Ophthalmology Medicare: Medicare Enrolled Practice Location: 216 Mill St, Bristol, PA 19007 Phone: 215-781-2020 |